Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

The epidermal growth factor receptor (EGFR) is often amplified and rearranged structurally in tumors of the brain, breast, lung, and ovary. The most common mutation, EGFRvIII, is characterized by an in-frame deletion of 801 base pairs, resulting in the generation of a novel tumor-specific epitope at...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sampson, John H., Crotty, Laura E., Lee, Samson, Archer, Gary E., Ashley, David M., Wikstrand, Carol J., Hale, Laura P., Small, Clayton, Dranoff, Glenn, Friedman, Allan H., Friedman, Henry S., Bigner, Darell D.
Formato: Artigo
Idioma:Inglês
Publicado: The National Academy of Sciences 2000
Assuntos:
Biological Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC16575/
https://ncbi.nlm.nih.gov/pubmed/10852962
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares